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Résumé 
L'objectif principal de cette recherche était de mettre en avant des méthodes qui pourraient aider et nourrir les gestionnaires de la santé de prendre des 
décisions sur les maladies négligées et les plus précises sur la leishmaniose. Le présent ouvrage est une étude comparative évaluer les facteurs présentés dans 
un environnement de recherche à travers l'analyse des publications scientifiques et dans le secteur de la santé à travers l'analyse des brevets et comment ces 
deux zones sont reliées entre elles, le cas échéant. Au cours de cette recherche, nous avons appliqué des méthodes de données et d'analyse des réseaux sociaux 
dans la recherche, le traitement et l'analyse de ces informations et des réseaux en évaluant les relations entre les entités, les chercheurs et les brevets au fil des 
années. La dernière tentative de ce travail était de cartographier les intérêts sur la leishmaniose parmi les pays du monde et de sa dynamique sur les 13 
dernières années. 
Abstract 
The main objective of this research was to bring forward methods that might help and nourish health managers take decisions about neglected diseases, and 
more specific on Leishmaniasis. The present work is a comparative study evaluating factors presented within a research environment through the analysis of 
scientific publications and within the health industry through the analysis of patents and how those two areas are interconnected, if so. During the course of 
this research we applied methods of Data and Social Network Analysis in the search, treatment and analysis of such information and networks by evaluating 
the relationships between the entities, researchers, and patents along the years. The last attempt of this work was to map the interests on Leishmaniasis among 
the countries in the world and its dynamics on the past 13 years.  
1 Introduction 
The research universe defined for this study is on Leishmaniasis disease contained in the so-called neglected tropical diseases (NTD). The term NTD, which 
has been used since the mid 1990s, has become a ―brand-name‖ referring to a group of diseases that are especially endemic in low-income populations living 
in tropical and subtropical countries (Ramos, Gonzalez-Alcaide, e Bolanos-Pizarro 2013). However, up to this date, there are no clear or agreed definitions for 
what constitute a neglected disease. According to the 2010 report from the World Health Organization (WHO) ―Working to Overcome the Global Impact of 
Neglected Tropical Diseases‖ the NTDs affects more than 1 billion people around the world.  
The known diseases are defined by the WHO as types I, II and III where Leishmaniasis is considered a type III disease. This definition is followed by a great 
number of health organizations and ministries around the world. The definition in itself mixes a number of concepts together including the wealth of a country 
between rich and poor; the state of its development between developed and developing and most importantly a measure of the burden of diseases by the 
incidence of the disease within the population (CEWG 2012). The definitions themselves are combined such that:  
Type I diseases: are incident in both rich and poor countries, with large numbers of vulnerable populations in each. 
Type II diseases: are incident in both rich and poor countries, but with a substantial proportion of the cases in poor countries. 
Type III diseases: are those that are overwhelmingly or exclusively incident in developing countries.  
With regard to investments in the area, those diseases do not receive adequate attention for its treatment and eradication, which perpetuates the condition of 
people who are exposed to them (Morel et al. 2009). In order to treaty the problems involved with NTDs, or Leishmanisis specifically, it is necessary to 
understand its complexity. One of the ways to help this situation through research is to provide methods to analyze the context using a number of different 
instruments and approaches. The study of scientific publications and patents is part of what is involved and this present work intends to show some of its 
benefits. 
In regard to scientific publications, there are a number of databases that catalogue journals on specific areas. Those databases are a very rich environment to 
understand the research world with information such as countries involved on research, number of publications per year and collaboration among institutions, 
countries and researchers. However, due to the large number of publications, journals and databases it is necessary to define clear methods that can bring 
valuable information at the right time. The analysis of patents is also used to measure and understand the growth or declined interest of countries and 
organizations within the NTD context. Through its analysis a great number of information might surface, such as companies and research institutions 
involved, countries health and economical policies and others.  
A number of publications on co-authorship and patents on NTDs specific diseases have been published in recent years. It‘s imperative that new tools and 
approaches being developed focus on facilitating public policy planning and foster the management of innovation in countries‘ public health systems 
(Vasconcellos and Morel 2012). On Leishmaniasis a recent bibliometric study (Ramos, Gonzalez-Alcaide, e Bolanos-Pizarro 2013) used one of the databases 
included in our work, helping making a comparison of the results. One of the results found was that the number of publications on the area has increased 
considerably on past years. A comparison with results from another research (Newman 2004) has also been made in regards to the same database using a co-
authorship analysis. 
2 Data Analysis of a Neglected Disease 
The research universe on Leishmaniasis for this paper has been made through the analysis of two different databases, PubMed and PASCAL, for scientific 
publications and one agency, The United States Patent and Trademark Office (USPTO) for patents and patent‘ applications. The reason behind the use of two 
different databases on scientific publications was to analyze if there were significant differences that might bias ones research. The access to the databases 
occurred during the month of May and June, 2013. We have decided to take into consideration only the publications and patents from 2000 to 2012 included. 
2.1 Method for Data Treatment 
For the data treatment and analyses we used the software Tetralogie. The software allows (several and remote users) to conduct strategic analysis from 
heterogeneous textual data through analysis of conventional and innovative methods. With statistical methods and exploratory data analysis methods, it shows 
strategic information such as actors identity, mobility, emergence and evolution of topics, concepts and terminology. Another feature of the software is that it 
allows graphical visualization for understanding human activities and their interactions as well as their evolution in a decision-making perspective. It 
combines static and dynamic visualization where the static aspect is based on a representation space, in which the precepts of graph theory are applied. The 
dynamic visualization applies features and capabilities to further understand evolution of the data and facts in respect to time. Tetralogie allowed us to identify 
the role of data within the structure, analyzing their neighborhood, filtering, k-core, transitivity, back to the source documents, to partition the graph or to 
focus on its structural features. 
2.2 Database 
The research have been made taking into consideration authors of articles and patents, countries where those authors were from, journals used for the scientific 
publications besides companies, universities and research institutions involved on both articles and patents. For all the information analysed the years of 
publication for scientific publications and of deposit for the patents were added to the analysis in order to understand the dynamics of the area within the past 
12 years. The PubMed platform, which holds the Medline Database, was used for the research as one of the databases. PubMed is a free database accessing 
references and abstracts on life sciences and biomedical topics. Data files were retrieved from PubMed with the Medical Subject Headings (MeSH) terms or 
descriptors ―Leishmaniasis‖ and ―Leishmania‖ for title and abstract, for the years 2000 to 2012. The second database used for the scientific publications was 
PASCAL. Pascal is a multidisciplinary and multilingual bibliographic database. It covers most of the world literature in Science, Technology and Medicine 
since 1973. The same search terms, dates and review of the data applied to PubMed was applied to PASCAL. After reviewing the data we decided to discard 
all the articles which contained the word ―clinical‖ explicitly on their titles or abstracts. We decided for this path on the bases that clinical trials is a post 
discovery phase which might bias the understanding of innovative contribution on the area and the consequent interest of scientific community and 
corporations. For the patents we have used the USPTO web site for the data retrieval. The search terms used had the same characteristics as for the scientific 
publications plus the medicines used to treat the illness as stated on the United States National Institute of Health (NIH) web site 
(http://www.ncbi.nlm.nih.gov/ access june 2013); sodium stibogluconate, meglumine antimoniate, macrolide, benzamidine, phosphorylcholine and neomycin. 
2.2.1 PubMed and PASCAL scientific publications 
The scientific databases are both well known and largely used by the academic community. Their differences however could help future researches taking into 
consideration aspects that might be important for more precise studies. The total number of publications between both databases diverge almost 3 folds for 
PubMed having a total of 9,210 articles for the period with the filtering mentioned before against 3,650 publications in PASCAL. The total number of Journals 
has also a great difference with PubMed covering 1,114 journals while PASCAL covers 362. This difference suggests that PuBMed has a much higher 
coverage in terms of absolute numbers. However, PASCAL has a more detailed qualification of the data concerning the countries where the authors are 
coming from. This is an important information if ones research aims to understand which countries are making the most contribution and the cooperation 
existent on research world. A slight difference in regards to country publications rank was noticed on the total number of articles per country, where USA, 
France, Belgium, Tunisia and Turkey had one or two places higher ranked in PASCAL, while Italy is 5 times lowered ranked. We also analyse the average of 
information per article concerning MESH words and key words but it was not found any significant difference among the databases. 
2.2.2 Patents 
For the patents we used the USPTO database, retrieving data for patents that has already been published as well as patents applications. The total number of 
patents and applications found were respectively 810 and 680. The number of authors for those patents and applications were respectively 1,610 and 1,435. 
We will discuss further on how those authors interact with each other showing a clear difference from collaboration in comparison to academic researchers. In 
respect to the number of companies or organizations whom own the patent there are further analysis that must be done in regards to the applications, which 
shows in most cases not the owner but its legal representative. In total there were 332 different organizations for the patents and 217 for the applicants. Out of 
those organizations 15 of them have 5 or more patents and 9 of them has 5 or more applications with United States, Japan and Germany alone with more than 
50% of all the patents and applications on the area. 
3 Results 
One of the results of our study was the absolute number of publications for each database per year as shown on figures 1 and 2. Figure 1 shows a steady 
increase for the scientific publications with a greater ratio for PubMed in comparison to PASCAL. For the year 2012 the PASCAL data shows a decrease in 
numbers of publications compared to 2011, however this might happen due to a delay on the processing of new publications. This difference for the year 2012 
for PASCAL database deserves a further study. As for the patents and patents‘ applications there was an increase on the years 2000 to 2003 with a clear drop 
and further fluctuation for the following years. After 2005 there is a downturn over the patents and applications on the area. However, due to a processing 
delay for patents, which might take from 2 to 12 years in some cases, the actual numbers of approved patents might change significantly. 
The comparison between the two areas, academic and commercial, brings a view over the interest in Leishmaniasis research and production. Because 
neglected diseases over past years has shown not to bring great revenue for pharmaceuticals corporations, in comparison to other areas, the numbers of patents 
and applications might have decreased as a consequence. On the other hand, the problem for developing countries and the number of people affected by those 
illnesses has forced emerging countries such as Brazil and India to invest on scientific research. Another very important player on the area are the Non 
Governmental Agencies (NGO), such as Medecins Sans Frontiers (MSF) and Drugs for Neglected Diseases initiative (DNDi), which has helped bring 
lowered prices medicines and treatments for the needs. 
 Figure 1 – Total Number of Scientific Publications 
Concerning the journals used by the researchers for publications the 20 most frequent journals in PASCAL where found amongst the first 30 journals in 
PuBMed. On the other hand, out of the 20 journals most used by researchers on PubMed only 9 were found amongst PASCAL database. A list of the first 20 
journals for each database is shown on table 1 with the numbers of publications for the period analyzed on the left column. Noticed that the first journals on 
PASCAL database, marked with the arrowed lines, are all present on PubMed but it doesn‘t hold true for the other way around. 
 
Figure 2 – Total Number of Patents and Patents Applications 
The study of the journals and its publications might help understand the interest that the journals might have. For the purpose of this study we concerned 
ourselves with the absolute number of publications in order to understand the increase or decrease of interest over the years. We have not used the impact 
factor for each journal in this study because we understand that there is a further analysis that might be necessary. This analysis is concerned with the 
characteristic of each journal. Some journals want to be on the leading edge of scientific publications, other journals might start publications in a certain area 
only after a few years that a topic became settled among the scientific community. This type of study would help understand and better qualify journals. 
Table 1 - Journals with most Publications from 2000 to 2012 
# Pub PASCAL Database # Pub PubMed Database 
200 The American Journal Of Tropical Medicine And Hygiene     253 Molecular And Biochemical Parasitology     
197 Experimental Parasitology     237 Experimental Parasitology     
192 Infection And Immunity     213 Memorias Do Instituto Oswaldo Cruz     
178 Parasitology Research 210 The American Journal Of Tropical Medicine And Hygiene     
143 Acta Tropica     197 The Journal Of Biological Chemistry     
127 Transactions Of The Royal Society Of Tropical Medicine And Hygiene 197 Infection And Immunity     
117 International Journal For Parasitology     183 Parasitology Research     
113 Antimicrobial Agents And Chemotherapy     173 Journal Of Immunology (Baltimore Md. : 1950)     
102 Vaccine     158 Transactions Of The Royal Society Of Tropical Medicine And Hygiene 
100 Annals Of Tropical Medicine And Parasitology     156 Revista Da Sociedade Brasileira De Medicina Tropical     
99 Parasitology 154 Acta Tropica     
69 Journal Of Medical Entomology        138 Plos Neglected Tropical Diseases     
68 Microbes And Infection     127 International Journal For Parasitology     
67 Bioorganic & Medicinal Chemistry     122 Veterinary Parasitology     
66 European Journal Of Medicinal Chemistry     120 Antimicrobial Agents And Chemotherapy     
61 Trends In Parasitology     109 Vaccine     
58 Bioorganic & Medicinal Chemistry Letters  107 Plos One     
57 The Journal Of Infectious Diseases     106 Annals Of Tropical Medicine And Parasitology     
56 Tm & Ih. Tropical Medicine & International Health     105 Parasitology     
54 Molecular Microbiology  82 European Journal Of Immunology
On tables 2 to 5 we show the number of publications for each database by year and per country. The first two tables, 2 and 3, shows the publications for 
PASCAL  and PubMed. It can be seen that there is very few differences among the leading countries concerning the total number of publications with Brazil, 
USA, India, UK and France as the top 5 countries. In regard to the years we can see a steady increase in publications over the years, as shown also in figure 1, 
with a decrease for the year 2012 for PASCAL database.  
Table 2 - PASCAL Number of publications by country and year Table 3 - PubMed Number of publications by country and year 
Figures 3 and 4 show the data on tables 2 and 3 in a graph format without the total sum. 
         Figure 3 – PASCAL top countries Publications         Figure 4 – PubMed Top countries Publications 
The same data used on table 2 and 3 is showing on figures 4 to 5 in terms of publications and patents per country. The figures only show the sum over the 12 
year period. The lighter the green the greater the number of publications and patents. The countries in red or orange have no recorded publication or patent on 
the databases used. This map can give an idea of how spread is the scientific publications and patents around the world. 
  
Figure 5 – PASCAL – Global view of Scientific Publications   Figure 6 – PubMed - Global view of Scientific Publications 
As for the Patents and applications, the tables 4 and 5, we have both USA and Japan as the main countries with patents over the disease with countries in west 
Europe following those. Concerning the number of patents over the years we can‘t see an increase in interest over the area which diverges from the scientific 
community publications. 
 
               Table 4 - Number of Patent publications by country and year    Table 5 - Number of Patent applications by country and year 
       
 
   
3.1 Author Turnover 
Another approach on our study have been done on author turnover for scientific publications attempting to understand how often there are new people coming 
in to the field and if experienced researchers are leaving to other areas of study. This analysis might show how settled an area of research is and how it brings 
interest for new scientists. In figures 6 and 7 we show the turnover with a cutoff point for authors with a minimum of 10 publications on the area over the 12 
year period. If an author publishes an article after 4 years of not publishing on the area he is considered a new entrant or start. If an author, after publishing on 
the field stop publishing for at least 4 years, on the fifth year he is marked as leaving the field or stop. The graph shows that, out of all the authors with 5 or 
more publications on the area, 12% by the year 2005 on PubMed were entering the field, against 1% leaving the field for the same period. There is a clear 
pattern seen of both databases where in the begin of the period studied there were many new entrants then people leaving the field. This shows an influx of 
new people in the field for that period. The absolute number of new entrants has grown each year until 2009 for PASCAL and 2010 for PubMed. Since then 






















Figure 7 – PASCAL – Turnover authors with 10 or more publications 
Figure 8 – PubMed - Turnover authors with 10 or more publications 
Figure 7 brings the same information for author turnover in a different view. The years, as shown in the top left part of the figure and pointed out in red on the 
bigger picture, show the years spread across the quadrants. The circles in yellow show the concentrations of authors which have published around those 
periods. A great majority of authors are in the field through out the entire period (centre of the graph) while others have written mostly around the year 2000, 
or around years 2010 to 2012 on leftmost and rightmost circles on the figure. The bottom circle show authors which have written in the begin of the period and 
have come back again on the last years. We can also see that the top right quadrant is the densest demonstrating a greater concentration of authors.
Figure 9 – PubMed – Author Turnover with 10 or more publications
 Figure 10 – Patent co-authorship 
3.2 Social Network 
Another line of research for the data collected for this work was the co-authorship on scientific publications and patents. People working together might 
demonstrate a type of relationship in which ―most people who have written a paper together will know one another quite well‖ (Newman 2001). However this 
might not hold true for all the cases. In our study we have found 3 papers with more than 100 contributors for PubMed and 2 papers with more than 60 
contributors for PASCAL. Those high numbers might suggest that on some cases the researchers do not necessarily know each other ―quite well‖. Those 
articles with a high number of contributors are not the average, as the numbers of Authors per Article (6,24 and 5,47 for PubMed and PASCAL) have shown 
but must be taken into consideration, specially when reviewing the clustering coefficient (Watts e Strogatz 1998). The clustering coefficient measures network 
‗‗clustering‘‘ or ‗‗transitivity,‘‘ which is the probability that two of a scientist‘s coauthors have themselves coauthored a paper. In science a high clustering 
coefficient would suggest that people are working together quite often, while a very detached network, as in patents, might suggest that people very rarely 
contribute with people outside its group. By removing some of the clinical trial papers from our database, some of the articles with an average of high 
contributors per paper have also been taken away.  
For the scientific publications we used a similar approach from Newmans‘ coauthorship paper (Newman 2004). In his article he used three different databases 
to understand the relationship amongst authors in a field. One of the databases used were the Medline, also used on our research. The difference however was 
that Newman analysed all the fields on Medline together, while in our case we restricted ourselves to Leishmaniasis. This difference accounted for a 
divergence on the clustering cofficent in Medline data but in line with the other scientific databases studied. The table 7 show the numbers of articles, authors, 
authors per article, journals and clustering coefficient for PubMed and PASCAL. 
Table 6 – Co-authorship table 
For the analyses of the co-authorship for patents we show on figure 8 the clusters which are formed amongst the authors. The figures gives a clear idea of how  
few contributions are made intra companies. Most of the authors shown, with the exception of 3 networks, works entirely for one corporation. The picture 
shows a great number of cluster very much disconnected. Besides very few authors do have relationships with other groups. This is a much different picture 
than with Academic collaborations, where the authors have a much higher tendency of sharing their discoveries and works with others in the field. 
Another relationship we have analysed over the study was if there are companies or research institutions that publish regularly scientific papers and also has 
patents or applications in the field. We have found that 35 organizations among universities ad research institutions both private and governmental. 
The name of the organizations are shown on table 8. 
PASCAL PubMed 
Number of Articles 3650 9210 
Number of Authors 11330 21957 
Authors per Article 6,24 5,47 
Number of Journals 362 1114 
Clustering Coefficient 0,58 0,496 
Table 7 – Organizations that has scientific publications and patents 
Consejo Superior De Investigaciones Cientificas  Rosalind Franklin University Of Medicine And Science 
Corixa Corporation     Swiss Tropical And Public Health Institute 
Council Of Scientific & Industrial Research The Ohio State University 
Emory University     The Salk Institute For Biological Studies 
Fundacao Oswaldo Cruz    The University Of Mississippi   
Georgia State University    Tokai University     
Hoshi University     Universidad De Granada    
Indian Council Of Medical Research  Universite Laval     
Infectious Disease Research Institute   Universite Pierre Et Marie Curie  
Institut De Recherche Pour Le Developpement University Of Alabama At Birmingham  
Institut National De La Recherche Agronomique University Of Bern   
Institut Pasteur     University Of Mississippi   
Institut Pasteur De Tunis   University Of Strathclyde   
Intervet International B.V. University Of Victoria    
Johns Hopkins University Virginia Polytechnic Institute And State University 
Mcgill University Washington University     
National Institutes Of Health Yale University 
Rockefeller University 
4 Conclusion 
This study was an attempt to bring forward some methods to analyze data focusing on a Leishmaniasis, a neglected disease. We have used data and network 
analysis tools on scientific databases and patents. This line of research have been made by different authors before and now we aimed at bringing together 
some of the techniques used. 
As for the findings on the field we can say that there have been an increase interest by the scientific community over the years, but it might be diminishing. 
For corporations we have not found as increase in interest over the area. However recent studies have shown an interest over the field by median and small 
size pharmaceuticals due to public and private partnerships involving some of the NGOs in the area. This line of research deserve a further study in order to 
understand how those different groups interact with each other. As for the countries we have shown a increase of interest by countries such as Brazil and India 
while a steady participation by countries such as USA, and western Europe, specially France, UK and Germany. 
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